The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksHNT.L Share News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Huntsworth Agrees GBP400 Million Cash Offer From US Private Equity

Tue, 03rd Mar 2020 10:46

(Alliance News) - Huntsworth PLC on Tuesday posted a rise in 2019 profit and said that it has agreed to a cash takeover offer valuing the company's share capital at GBP400 million.

CD&R Artemis UK Bidco Ltd, an entity formed by US private equity Clayton Dubilier & Rice LLP, will pay 108 pence per share in cash for healthcare and communications firm Huntsworth. This represents around a 50% premium to the company's 72.0p per share Monday closing price.

On Tuesday morning, shares in Huntsworth were up 51% at 109.00p in London.

The implied enterprise value of the acquisition, intended to be implemented through a court-sanctioned scheme of arrangement, is GBP524 million.

The deal has been unanimously recommended by Huntsworth's directors. Clayton Dubilier has received irrevocable undertakings from Merian Global Investors (UK) Ltd and Hargreave Hale Ltd- holding a combined 14% take in Huntsworth.

Letters of intent to vote in favour have also been received from Aberforth Partners LLP, Kabouter Management LLC and Kames Capital, holding a combined 22% stake. With these and director acceptances, Clayton Dubilier has acceptances representing 37% of Huntsworth's share capital.

Huntsworth's 2019 pretax profit totaled GBP29.8 million, up 4.2% from GBP28.6 million. This resulted from an 18% revenue rise to GBP264.9 million from GBP225.0 million, including a 32% rise in Marketing revenue to GBP108.3 million from GBP82.0 million and 32% Medical revenue rise to GBP45.1 million from GBP34.2 million, thanks to acquisitions.

The company has proposed a final 1.85p per share dividend, taking the total for 2019 up 13% to 2.6p per share from 2.3p per share.

Huntsworth Chief Executive Paul Taaffe said: "Huntsworth had yet another record year led by growth in our Medical and Immersive divisions and a return to growth in Communications. Organic revenue growth accelerated over the course of the year and the acquisitions of Kyne in Marketing and Creativ-Ceutical in Medical both contributed to 2019 performance and further enhanced our capability to attract larger and higher-margin client engagements.

"We have entered 2020 well positioned for another year of growth with strong momentum at the start of the financial year and an increased new business pipeline."

On the takeover offer, Taaffe said: "Whilst we believe that Huntsworth is strongly positioned as an independent listed company, the all-cash offer from CD&R represents a compelling opportunity for shareholders to realise an attractive cash value in respect of their shares."

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2019 09:31

UK BROKER RATINGS SUMMARY: JPMorgan Cuts Rio And BHP, Raises Anglo

UK BROKER RATINGS SUMMARY: JPMorgan Cuts Rio And BHP, Raises Anglo

Read more
17 Dec 2019 08:16

Huntsworth on track to meet expectations

(Sharecast News) - Huntsworth said it was on track to meet annual profit expectations after its marketing division returned to growth.

Read more
6 Nov 2019 08:44

Redrow Performance Improves Despite Weak Demand; Adds To Board

Redrow Performance Improves Despite Weak Demand; Adds To Board

Read more
29 Oct 2019 16:41

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
2 Oct 2019 11:37

Huntsworth Promotes Finance Head To Board As Chief Financial Officer

Huntsworth Promotes Finance Head To Board As Chief Financial Officer

Read more
23 Jul 2019 11:29

Huntsworth Optimistic On Full Year Despite Swinging To Interim Loss

(Alliance News) - Healthcare public relations group Huntsworth PLC on Tuesday swung to an interim loss, mainly due to a sharp rise in finance costs.Huntsworth posted a pretax loss of GBP1.1

Read more
16 Jul 2019 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 17 July Watches of Switzerland GroupFull Year Results Premier OilTrading

Read more
10 Jul 2019 12:13

Huntsworth Non-Executive To Step Down To Join BioMarin Pharma Board

(Alliance News) - Healthcare communications firm Huntsworth Group PLC said Wednesday that Non-Executive Director Elizabeth Anderson will step down with effect from December 31.Anderson will

Read more
21 May 2019 10:57

Huntsworth adds Creativ-Ceutical and Kyne to its portfolio

(Sharecast News) - Healthcare and communications group Huntsworth announced the acquisition of 70% of Luxembourg-based Creativ-Ceutical (CC) from 100% shareholder Avicenne Invest for an initial cash consideration of €15.5m on Monday.

Read more
6 Mar 2019 14:57

PageGroup's David Lowden Joins Huntsworth Board As Chair

LONDON (Alliance News) - Healthcare and communications firm Huntsworth PLC on Wednesday confirmed David Lowden has now joined the company as chair.Lowden's appointment was first with at

Read more
5 Mar 2019 10:30

Huntsworth Hikes 2018 Dividend After Profit, Revenue Jump On Buyouts

LONDON (Alliance News) - Healthcare and marketing services firm Huntsworth PLC hiked its 2018 dividend Tuesday after profit and revenue jumped amid a series of acquisitions, as it focuses on the a

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
24 Jan 2019 15:09

Thursday broker round-up

(Sharecast News) - Reckitt Benckiser: Jefferies downgrades to underperform with a target price of 5,000p.

Read more
12 Dec 2018 10:15

Huntsworth Expects Double-Digit Annual Profit Growth On Higher Revenue

LONDON (Alliance News) - Huntsworth PLC on Wednesday said it expects to achieve market expectations in 2018, helped by strong growth in Medical and Immersive divisions.The stock was trading

Read more
12 Dec 2018 09:59

Huntsworth to finish year in line with market expectations

(Sharecast News) - International healthcare and communications group Huntsworth updated the market on its trading for the 11 months to 30 November on Wednesday, reporting that it continued to trade well and expected to reach at least market consensus headline profit estimates for the year ending 31 December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.